About Dr. Kudva

Yogish Kudva, MBBS, has three main research interests:

  • Development of an effective artificial pancreas system for people with type 1 diabetes using the closed-loop system of insulin delivery and glucose sensing (primary interest). Along with co-principal investigator Ananda Basu, MBBS, M.D., Dr. Kudva has been successful in securing funding from the National Institutes of Health for an artificial pancreas program. To supplement federal funding, Dr. Kudva and Dr. Basu are in the process of applying to other organizations and seeking benefactor support. They have also recently accepted an invitation from the Juvenile Diabetes Research Foundation to join its Artificial Pancreas Project Consortium.
  • Effective and safe pancreas transplantation for type 1 diabetes. Dr. Kudva works closely with Mayo's kidney/pancreas surgical team and his nephrology transplant colleagues to continually improve pancreatic transplant outcomes. Mayo's pancreas transplant program in Rochester, Minn., provides long-term insulin independence for more than 60 percent of transplant recipients, and freedom from hypoglycemia and ketoacidosis for more than 80 percent of transplant recipients.
  • Stem cell therapy for type 1 diabetes. Dr. Kudva collaborates with Yasuhiro Ikeda, D.V.M., Ph.D., in the Department of Molecular Medicine in developing stem cell therapies for people with type 1 diabetes.